Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 10, Issue Suppl 2
244 AFNT-111, a safe and effective TCR-engineered T cell therapy targeting the oncogenic driver KRAS G12V mutation
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Regular and Young Investigator Award Abstracts
Cell Therapies
244 AFNT-111, a safe and effective TCR-engineered T cell therapy targeting the oncogenic driver KRAS G12V mutation
Free
Online download statistics by month:
Online download statistics by month: November 2022 to September 2024
Abstract
Full
Pdf
Nov 2022
375
0
34
Dec 2022
100
0
16
Jan 2023
98
0
13
Feb 2023
92
0
16
Mar 2023
128
0
23
Apr 2023
96
0
14
May 2023
94
0
11
Jun 2023
62
0
7
Jul 2023
86
0
10
Aug 2023
88
0
2
Sep 2023
44
0
6
Oct 2023
46
0
5
Nov 2023
74
0
12
Dec 2023
74
0
6
Jan 2024
30
0
5
Feb 2024
16
0
2
Mar 2024
56
0
4
Apr 2024
82
0
6
May 2024
86
0
10
Jun 2024
68
0
6
Jul 2024
110
0
4
Aug 2024
68
0
5
Sep 2024
62
0
7
Total
2035
0
224
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?